Cell and gene therapy

Why choose our Cell and Gene Therapy lawyers?

Even though CGT is attracting significant attention from various stakeholders, the route to market is far from straightforward with businesses having to overcome significant legal bottlenecks along the way to get treatments to patients.

Fieldfisher's pan-European life sciences lawyers have an in-depth understanding of the CGT space. We have a wealth of experience working with and advising the key players involved in the process from lab to patient on an international scale, from ambitious ATMP producers, usually academic institutions to development and manufacturing partners, larger pharmaceutical and biotechnology companies, investors, regulators and industry lobby groups.

With experts across regulatory, intellectual property, data protection, commercial and corporate law, we take a holistic approach to working with clients at every stage of their CGT journey.